title: Phase II trial of epirubicin at standard dose in relapsed ovarian cancer.
authors.forename: I
authors.initials: I
authors.lastname: Peláez
authors.forename: A J
authors.initials: AJ
authors.lastname: Lacave
authors.forename: I
authors.initials: I
authors.lastname: Palacio
authors.forename: E
authors.initials: E
authors.lastname: Alvarez
authors.forename: J F
authors.initials: JF
authors.lastname: Cueva
authors.forename: I
authors.initials: I
authors.lastname: Muñiz
authors.forename: F
authors.initials: F
authors.lastname: Arranz
authors.forename: J
authors.initials: J
authors.lastname: Fra
mesh_terms: D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D015251:Epirubicin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D000903:Antibiotics, Antineoplastic; D015251:Epirubicin